OMIX

Phase I study to evaluate the safety, tolerability, pharmacokinetic characteristics, and preliminary efficacy of BL-M02D1 for injection in patients with locally advanced or metastatic gastrointestinal tumors or other solid tumors

OMIX001687

1Summary
Title Phase I study to evaluate the safety, tolerability, pharmacokinetic characteristics, and preliminary efficacy of BL-M02D1 for injection in patients with locally advanced or metastatic gastrointestinal tumors or other solid tumors
Description Metabolic data of patients in project BL-M02D1-102
Organism Homo
Data Type Other Type of Metabolome Data
Data Accessibility Controlled-access
BioProject PRJCA011463
Release Date 2022-08-27
Submitter zhongxue li (lizhongxue@baili-pharm.com)
Organization Sichuan Baili Pharmaceutical Co., Ltd.
Submission Date 2022-08-26
2Files & Download

HTTP download speed may be slow. It is highly recommended that you download the dataset using a dedicated FTP tool (such as FileZilla Client).

File ID File Title Number/Samples File Type File Size File Suffix Download Times Download
OMIX001687-01 BL-M02D1-102-metabolic 6 Other Type of Metabolome Data 59.9 KB rar 0 Controlled

Request for this Data View All Released Data of OMIX